Cizzle Biotechnology (LON:CIZ) Stock Price Up 1.4% – Should You Buy?

Cizzle Biotechnology Holdings Plc (LON:CIZ) shares were up 1.4% on Wednesday . The company traded as high as GBX 2.60 and last traded at GBX 2.54. Approximately 193,484 shares changed hands during trading, a decline of 87% from the average session volume of 1,519,876 shares. The stock had previously closed at GBX 2.50.

Cizzle Biotechnology Price Performance

The stock has a market capitalization of £10.20 million, a P/E ratio of -14.12 and a beta of 0.02. The business’s 50 day simple moving average is GBX 2.87 and its 200-day simple moving average is GBX 2.14.

Cizzle Biotechnology (LON:CIZ) last issued its earnings results on Tuesday, May 5th. The company reported GBX (0.17) EPS for the quarter.

Cizzle Biotechnology Company Profile

Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.